Pulmonary Arterial Hypertension Market Supported by Biomarker Research

added blog Other

2025-05-29 07:57:12 -

According to a recent report by Grand View Research, Inc., the global pulmonary arterial hypertension (PAH) market is projected to reach USD 11.02 billion by 2030. From 2024 to 2030, the market is expected to grow at a robust compound annual growth rate (CAGR) of 5.4%. This growth is primarily driven by factors such as the rising prevalence of PAH, continued drug development,...

0 Comments 0 Shares 66 Views 0 Reviews